Objective To explore the mechanism of regulatory effects of miR-138 overexpression through inhibiting TCF-4 expression on the proliferation, apoptosis and movement of thyroid carcinoma cell line CAL-62. Methods miR-138 mimic was transfected into CAL-62 cells, and detected by RT-PCR. After overexpression of pcDNA vector, TCF-4 was transfected into CAL-62 cells, and Western blot was used to detect the expression levels of TCF-4, proliferating nuclear antigen 67 (Ki67), proliferating cell nuclear antigen (PCNA), caspase-3, caspase-9, E-cadherin, Vimentin and target genes cycD and c-Myc. EDU staining was used to detect the cell proliferation. Hoechst staining was used to detect the cell apoptosis, and transwell was used to detect the cell invasion ability. Results Compared with the control group, the protein expression levels of caspase-3, caspase-9 and Vimentin in miR-138 transfection+TCF-4 group were significantly decreased (P<0.01). The protein expression levels of Ki67, PCNA, E-cadherin, cycD and c-Myc were significantly increased (P<0.01). And the apoptosis of thyroid tumor cells was significantly inhibited (P<0.01), and the proliferation and invasion were significantly promoted (P<0.01). Compared with TCF-4 group, the protein expression levels of caspase-3, caspase-9 and Vimentin in miR-138 transfection+TCF-4 group were significantly increased (P<0.01). The protein levels of Ki67, PCNA, E-cadherin, cycD and c-Myc were significantly decreased (P<0.01). Proliferation and invasion of thyroid tumor cells were significantly inhibited (P<0.01), as well apoptosis was significantly promoted (P<0.01). Conclusions miR-138 overexpression can significantly inhibit the proliferation and invasion and significantly promote the apoptosis of thyroid cancer cell line CAL-62, by inhibiting TCF-4 expression.
Key words
/
miR-138 /
TCF-4 /
CAL-62 /
Proliferation /
Apoptosis
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Cabanillas ME, Mcfadden DG, Durante C. Thyroid cancer[J]. Lancet, 2016, 388(10061): 2783.
[2] 林清英, 陈志辉. 甲状腺癌相关影响因素研究进展[J]. 中国地方病防治杂志, 2016, 12(3): 260-263.
[3] Hu J, Li C, Liu C, et al. Expressions of miRNAs in papillary thyroid carcinoma and their associations with the clinical characteristics of PTC[J]. Cancer Biomarkers, 2017, 18(1): 87.
[4] Thompson LD. Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: a name change to noninvasive follicular thyroid neoplasm with papillary-like nuclear features would help prevent overtreatment[J]. Mod Pathol, 2016, 29(7): 698-707.
[5] Pacini F, Castagna MG, Cipri C, et al. Medullary thyroid carcinoma[J]. Clin Oncol, 2010, 22(6): 475-485.
[6] Zhao HD, Tang HL, Liu NN, et al. Targeting ubiquitin-specific protease 22 suppresses growth and metastasis of anaplastic thyroid carcinoma[J]. Oncotarget, 2016, 7(21): 31191-31203.
[7] 林明政, 沈国栋, 沈干, 等. T细胞因子4在胃癌细胞增殖凋亡中的作用研究[J]. 安徽医科大学学报, 2016, 51(8): 1092-1096.
[8] 肖丽容, 郑仕洁, 侯宸, 等. 小鼠视网膜体外电转化及Transwell体外培养的方法[J]. 眼科新进展, 2018, 38(7): 620-624.
[9] Boehm EM, Gildenberg MS, Washington MT. The many roles of PCNA in eukaryotic DNA replication[J]. Enzymes, 2016, 39(8): 231-254.
[10] 陈红, 王晓辉, 易田. 卵巢癌中GnRH及其受体的表达与细胞增殖和分化的关系[J]. 中国妇幼保健, 2008, 23(20): 2865-2867.
[11] 石小燕, 胡国清, 曹荣华. 细胞周期素D1和Ki67在鼻咽癌中的表达及意义[J]. 中华放射肿瘤学杂志, 2003, 12(4): 273-274.
[12] Lu W, Lu T, Wei X. Downregulation of DNMT3a expression increases miR-182-induced apoptosis of ovarian cancer through caspase-3 and caspase-9-mediated apoptosis and DNA damage response[J]. Oncol Rep, 2016, 36(6): 3597-3604.
[13] 孙桂超, 邹翔, 季宇彬. 细胞凋亡线粒体途径机制的研究[C]// 2009医学前沿论坛暨全国肿瘤药理与化疗学术会议, 2009.
[14] 洪甜, 李玲, 李文超, 等. 人Six1基因缺失突变体对上皮钙黏素(E-cadherin)启动子活性的影响[J]. 细胞与分子免疫学杂志, 2016, 32(2): 224-227.
[15] 任本洪, 孙雪娇, 郝跃鹏, 等. Aurora蛋白激酶抑制剂VX-680对人肝癌细胞HepG2细胞间同质黏附力和迁移能力的影响[J].中国病理生理杂志, 2018, 34(5): 945-949.
[16] Gao M, Zhang X, Li D, et al. Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma[J]. Oncotarget, 2016, 7(51): 85502-85514.
[17] Lazarova D L, Bordonaro M. Vimentin, colon cancer progression and resistance to butyrate and other HDACis[J]. J Cell Mol Med, 2016, 20(6): 989-993.
[18] 金波, 高亮, 李望, 等. LIM和SH3蛋白1蛋白在肾透明细胞癌组织中的表达及其对肾透明细胞癌786-O细胞侵袭和迁移能力的影响[J]. 中华肿瘤杂志, 2017, 39(3): 166-171.
